Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $0.91 | $0.83 | 9.64 % |
Q3 | 2024-11-06 | $0.79 | $0.70 | 12.9 % |
Q2 | 2024-07-30 | $0.89 | $0.70 | 27.1 % |
Q1 | 2024-05-07 | $0.62 | $0.62 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $187.25M | $185.38M | 1.01 % |
Q3 | 2024-11-06 | $168.57M | $169.67M | -0.65 % |
Q2 | 2024-07-30 | $178.02M | $172.48M | 3.21 % |
Q1 | 2024-05-07 | $167.12M | $165.35M | 1.07 % |
Pacira BioSciences (PCRX) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $0.91, which beat the estimate of $0.83.
The Actual Revenue was $187.3M, which beat the estimate of $185.4M.
Browse earnings estimates, EPS, and revenue on all stocks.